Background: there is a strong relationship between epicardial fat thickness and severity of coronary artery disease. The impact of diabetes on severity of coronary artery disease (CAD) is well known. The possible impact of diabetes on the relationship between EFT and severity of CAD was not fully investigated.
INTRODUCTION
iabetes is a very important independent risk factor for the development of coronary artery disease¹. In addition to accelerated atherosclerosis, multiple dynamic factors related to diabetes not only predispose to acute myocardial infarction but also contribute to post-infarction complications². Epicardial fat tissue is an active tissue that originates from the same embryogenic layer as visceral adipose tissue and contributes to the energy supply of the heart and its surrounding tissues, secretes hormones adiponectin and leptin and is also a local reserve for pro-inflammatory cytokines which is related to obesity, hypertension, insulin resistance and coronary artery disease³. Epicardial fat measurement may play a role in the stratification of the cardio-metabolic risk and serve as therapeutic target. Weight loss and anti-inflammatory drugs targeting the fat may modulate epicardial fat. Because epicardial and myocardial tissues share the same coronary arterial supply it is reasonable to hypothesize that improved local vascularization may resume epicardial fat to its physiological role⁴. In our study, we search for the impact of diabetes in the relationship between epicardial fat thickness and severity of coronary artery disease by Gensini score in non-ST elevation myocardial infarction patients. We exclude all patients with a history of coronary artery disease, heart failure (EF < 50), hepatic or renal failure, active or chronic inflammatory or autoimmune diseases, severe arrhythmia and patients with poor image quality in the echocardiographic examination. After assessment of detailed medical history and a complete physical examination, the baseline characteristics including age, sex, hypertension, T2DM, smoking status, family history of CAD, Waist circumference (was measured down to the 0.1 cm unit at the midpoint between the lower rib margin and the iliac crest)⁵, and previous medications were recorded for all patients. Venous blood samples were collected from all participants to measure complete blood picture, Serum creatinine with an autoanalyser and Highly-sensitive cardiac troponin I (hs-cTnI)
PATIENTS AND METHODS
Transthoracic echocardiography: Echocardiographic evaluation was done using the commercially available equipment, the digital ultrasound system (GE) Vivid S6 with a 2-to 3-MHz transducer. Standard parasternal long-axis and short-axis views from two-dimensional images were done for measurement of EFT on the free wall of the right ventricle while patients will be in left lateral decubitus position. M-mode, 2-dimensional and Doppler echocardiographic assessment was performed for all patients.
Assessment of the EFT EFT obtained by echocardiography is generally determined as (the relatively echolucent space between the outer wall of the myocardium and the visceral layer of pericardium; and is measured perpendicularly on the free wall of the right ventricle at endsystole in three cardiac cycles, the average value of three cardiac cycles from each echocardiographic view was determined) Angiographic assessment of severity of coronary artery disease by GENSINI SCORE Coronary angiography was performed by Judkins technique without nitroglycerin using 6-French right and left heart catheters. Coronary lesions leading to a diameter stenosis of ≥ 50% in vessels of ≥ 1.5 mm were scored separately. Angiogram was analyzed by two interventional cardiologists who were blinded to clinical status and laboratory measurements. After obtaining images by standard approaches, each angiogram was interpreted by two independent cardiologists. The severity of coronary artery lesions will be scored using a modified Gensini scoring system. STATISTICAL ANALYSIS Data were coded and entered using R language (R-studio Version 0.99.484 -© 2009-2015) for data analysis. Data are expressed as mean value ± standard deviation and percentage. Differences in frequency of characteristics were assessed by independent sample student's t-test for continuous variables. While Chi-square statistics used for discrete variables. A two-tailed P-value, 0.05 was considered statistically significant⁶. RESULTS The mean EFT values of diabetes and nondiabetes groups were 6.7 ± 1.3 mm and 5.4 ± 1.4 mm, respectively. While the mean GENSINI score values of diabetes and nondiabetes groups were 30.18 ± 16.09 mm and 20.75 ± 13.95 mm, respectively. (Table 1) EFT is associated with GENSINI score in all patients (r =0.53, P = <0.01), in non-diabetic group (r = 0.33, P= 0.04) and diabetic group(r = 0.66, P=0.01). DISCUSSION In our study we found high association between diabetes and Gensini score in non ST elevation myocardial infarction patients with significant correlation (p value <0.05). This was consistent with saleem et al⁷. Their study was performed to find the association between glycosylated haemoglobin (HbA1C) level and the severity of coronary artery disease. One hundred and ten consecutive patients admitted to hospital with acute myocardial infarction were studied. They found that there was a significant association between Gensini score and DM (p=0.003). Also, Lekakis et al.⁸ who studied the effects of traditional vascular risk factors such as diabetes on the atherosclerotic changes in the carotid , femoral arteries and on the extent and severity of coronary artery disease (CAD) confirmed this result. They found that diabetes mellitus can be an independent predictor of the extent and severity of CAD. We found a highly significant positive correlation between EFT and Gensini score (P value= 0.00007707) in all our NSTEMI patients. Our study is strongly in agreement with Eroglu et al⁹ who found a positive relationship between echocardiographic EAT thickness and severity of coronary artery disease by (Gensini score) in 150 patients. They concluded that EAT thickness, which is easily and non-invasively evaluated by transthoracic echocardiography, can be an adjunctive marker to classical risk factors for the prediction of CAD. Also, Jeong et al¹⁰ found that epicardial fat thickness was significantly correlated with the severity of coronary artery disease in patients with known coronary artery disease. These studies were confirmed by Shemirani and Meysam Khoshavi¹¹. Ahn et al¹² measured EAT thickness in 527 patients undergoing their first coronary angiography. The study revealed that patients with unstable angina had thicker EAT compared to those with stable angina or atypical chest pain. These results suggest that the echocardiographic measurement of EAT may provide additional information for assessing CAD risk and predicting the extent and activity of CAD. On the other hand, our study does not agree with Chaowalit et al¹³ study which concluded that the amount of subepicardial adipose tissue thickness was not associated with the severity of CAD. Their study was done on older patients (68 ± 13 years) that can make difference in results. Also there are differences in techniques used in measuring echocardiographic EFT; it was measured at end-diastole and severity of coronary artery disease was assessed by CAGE score while in our study EFT was measured at end-systole and severity of coronary artery disease was assessed by Gensini score. In our study, we found positive correlation between EFT and severity of coronary artery disease by Gensini score in non-diabetic group (P value =0.08599) with more significant correlation in the diabetic group (P value =0.00148). Sade et al¹⁴ indicated that EAT volume by cardiac multi-slice computed tomography is increased in T2DM patients and is associated with unfavorable components of metabolic syndrome and coronary atherosclerosis. The close anatomical relationship between EAT and the coronary arteries, combined with other evidence indicating that EAT is a biologically active adipokine-secreting tissue and participates in the pathogenesis of diabetic coronary atherosclerosis. CONCLUSION Epicardial fat thickness may be associated with the severity of CAD in both diabetic and non-diabetic non ST elevation myocardial infarction patients. However, there is a stricter relationship between EFT and the severity of CAD in diabetic patients.
